GeVIR Banner

Export Results to CSV Clear Search

Genes Fold Enrichment Color Codes
  • Gene Name, Canonical Transcript - gene identifiers from gnomAD database (Build 37)
  • GeVIR % - gene rank measured in percentiles based on Gene Variation Intolerance Ranking (GeVIR) (low values indicate more variation intolerant genes, which is also true for "LOEUF %" and "VIRLoF %"). GeVIR is a method which we developed and applied on a list of 19,361 genes to sort them based on number, length and evolutionary conservation of regions without functional variants (i.e. between two missense, loss-of-function, insertion or delition variants) in gnomAD database (version 2.0.1). Only canonical transcripts were analysed.
  • LOEUF % - gene rank measured in percentiles based gnomAD loss-of-function observed/expected upper bound fraction (LOEUF) (see Figure 1). For more information about this metric, please read "Constraint" section of MacArthur Lab blog post. If you use this metric please cite gnomAD flagship paper and use most up-to-date values from gnomAD website.

    LoF observed/expected (o/e) upper Confidence Interval (CI)

    Figure 1. Screenshot of ELN gene constraint metrics from gnomAD browser

  • VIRLoF % - gene rank measured in percentiles based on both GeVIR and gnomAD LOEUF (shows the best overall performance, see Figure 2). If you use this metric please cite both GeVIR and gnomAD flagship paper.
  • GeVIR AD, LOEUF AD, VIRLoF AD, GeVIR AR, LOEUF AR, VIRLoF AR - to help users interpret gene ranks, we calculated fold enrichment of Autosomal Dominant (AD) and Autosomal Recessive (AR) genes with known molecular basis of disorder in OMIM in a range of +-5% of gene X (see Figure 2). Statistical significant fold enrichements (Fisher Exact Test p-value < 1e-5) are shown in bold in the table. For example CDK19 gene's GeVIR % is 2.37, so examined range is from 0 (2.37-5, rounded to minimal percentile) to 7.37% (2.37+5). Genes in this range are ~4 times more often (4.05 fold enrichement) associated with AD diseases and ~4 times less often (0.25 fold enrichement) associated with AR diseases. Both enrichment of AD genes and deficiency of AR genes is statistical significant. Thus GeVIR metric adds supportive evidence that CDK19 is more likely to be associated with AD than AR disease.

    Gene Percentiles AD AR Fold Enrichment

    Figure 2. Fold Enrichment of known Autosomal Dominant (AD) and Autosomal Recessive (AR) genes of each gene in the ranked lists (GeVIR, LOEUF, VIRLoF. AD genes are enriched among top ranked genes (lowest percentiles), whereas AR genes are enriched among middle ranked genes (approximetly 35-65 percentiles). Combined metric (VIRLoF, purple) shows the best perfornance, i.e. high ranked genes are more often associated with AD than AR diseases, low ranked genes are less often associated with both AD and AR diseases.
Gene Name Canonical Transcript GeVIR % LOEUF % VIRLoF % GeVIR AD LOEUF AD VIRLoF AD GeVIR AR LOEUF AR VIRLoF AR
FP15737 ENST00000399967 91.41 98.40 97.79 0.15 0.21 0.09 0.20 0.14 0.04
AL590822.1 ENST00000545087 91.42 98.40 97.80 0.15 0.21 0.09 0.20 0.14 0.04
RNASE2 ENST00000304625 99.66 98.41 99.92 0.12 0.21 0.12 0.13 0.14 0.04
ERV3-1 ENST00000394323 83.95 98.41 94.06 0.29 0.21 0.09 0.48 0.14 0.12
MT1HL1 ENST00000464121 84.46 98.42 94.33 0.30 0.21 0.10 0.46 0.14 0.12
GRIK1-AS2 ENST00000333765 87.55 98.42 95.83 0.23 0.21 0.07 0.37 0.14 0.11
ERVW-1 ENST00000493463 72.29 98.43 88.58 0.34 0.21 0.22 0.80 0.14 0.28
USP17L5 ENST00000507227 91.46 98.43 97.82 0.15 0.21 0.09 0.20 0.14 0.04
MAGEA1 ENST00000356661 98.14 98.44 99.66 0.11 0.21 0.12 0.11 0.14 0.04
PPP1R26 ENST00000356818 68.04 98.45 86.80 0.57 0.21 0.29 1.03 0.14 0.32
AL627171.2 ENST00000595378 91.48 98.45 97.84 0.15 0.21 0.09 0.20 0.14 0.04
ANP32D ENST00000266594 96.26 98.46 99.24 0.12 0.21 0.11 0.11 0.14 0.04
LINC00346 ENST00000538077 95.50 98.46 99.04 0.11 0.21 0.11 0.11 0.14 0.04
AC011484.1 ENST00000377652 95.66 98.47 98.73 0.11 0.21 0.10 0.11 0.14 0.05
AC097381.1 ENST00000429019 91.53 98.47 97.60 0.15 0.21 0.09 0.20 0.14 0.06
TAS2R42 ENST00000334266 96.92 98.48 99.13 0.09 0.21 0.11 0.11 0.14 0.04
NAT8 ENST00000272425 88.12 98.48 96.14 0.20 0.21 0.07 0.35 0.15 0.10
C8orf49 ENST00000525043 95.12 98.49 98.93 0.10 0.21 0.10 0.12 0.15 0.04
C10orf85 ENST00000369071 91.60 98.49 97.24 0.15 0.21 0.08 0.20 0.15 0.06
IFNA17 ENST00000413767 96.77 98.50 99.36 0.11 0.21 0.11 0.11 0.15 0.04
MAGEA3 ENST00000393902 95.97 98.50 98.93 0.11 0.21 0.10 0.11 0.15 0.04
MAGEA12 ENST00000393900 97.43 98.51 99.31 0.10 0.21 0.11 0.11 0.15 0.04
MAGEB5 ENST00000602297 87.89 98.51 95.66 0.23 0.21 0.07 0.36 0.15 0.11
ZNF835 ENST00000537055 97.03 98.52 99.46 0.10 0.21 0.11 0.11 0.15 0.05
AC127496.1 ENST00000321930 91.64 98.52 97.92 0.14 0.21 0.09 0.20 0.15 0.04

Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.